Table 5.
TINCR polymorphisms and their association with cancer risk.
| Cancer type | Cases/Control | SNP ID | OR (95%CI) | p-value | Description | Reference |
|---|---|---|---|---|---|---|
| Gastric cancer | 602/602 | rs8113645 | 0.70 (0.55–0.89) | 0.003 | GA and AA genotypes were significantly associated with decreased GC risk. GA + AA genotype carriers had lower TINCR mRNA expression levels compared with common genotype in both normal and GC tissues. |
[32] |
| rs2288947 | 0.83 (0.70–0.99) | 0.037 | AG and GG genotypes were significantly associated with decreased GC risk. | |||
| Colorectal cancer | 1400/1400 (Stage I: 600, Stage II: 800) | rs2288947 | 0.77 (0.67–0.88) | 1.2 × 10−4 | The G allele was associated with 23% decreased risk of colorectal cancer. | [33] |
| rs8105637 | 1.22 (1.09–1.37) | 6.2 × 10−4 | The A allele was associated with 22% increased risk of colorectal cancer. |